[go: up one dir, main page]

FR2669221B1 - Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique. - Google Patents

Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique.

Info

Publication number
FR2669221B1
FR2669221B1 FR9014210A FR9014210A FR2669221B1 FR 2669221 B1 FR2669221 B1 FR 2669221B1 FR 9014210 A FR9014210 A FR 9014210A FR 9014210 A FR9014210 A FR 9014210A FR 2669221 B1 FR2669221 B1 FR 2669221B1
Authority
FR
France
Prior art keywords
tablets
preparation
acid derivatives
direct compression
cephalosporanic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9014210A
Other languages
English (en)
Other versions
FR2669221A1 (fr
Inventor
Laly Jean-Louis
Lombardi Roberto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Sante SA
Original Assignee
Rhone Poulenc Sante SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9014210A priority Critical patent/FR2669221B1/fr
Application filed by Rhone Poulenc Sante SA filed Critical Rhone Poulenc Sante SA
Priority to ES91920476T priority patent/ES2060417T3/es
Priority to US08/064,049 priority patent/US5514383A/en
Priority to EP91920476A priority patent/EP0557389B1/fr
Priority to DK91920476.8T priority patent/DK0557389T3/da
Priority to CA002094122A priority patent/CA2094122C/fr
Priority to PCT/FR1991/000872 priority patent/WO1992008463A1/fr
Priority to AT91920476T priority patent/ATE111734T1/de
Priority to JP50040992A priority patent/JP3253074B2/ja
Priority to DE69104220T priority patent/DE69104220T2/de
Priority to KR1019930701448A priority patent/KR100226386B1/ko
Publication of FR2669221A1 publication Critical patent/FR2669221A1/fr
Application granted granted Critical
Publication of FR2669221B1 publication Critical patent/FR2669221B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9014210A 1990-11-15 1990-11-15 Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique. Expired - Fee Related FR2669221B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR9014210A FR2669221B1 (fr) 1990-11-15 1990-11-15 Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique.
JP50040992A JP3253074B2 (ja) 1990-11-15 1991-11-08 直接圧縮によるセフアロスポラン酸誘導体の錠剤の製造方法
EP91920476A EP0557389B1 (fr) 1990-11-15 1991-11-08 Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique
DK91920476.8T DK0557389T3 (da) 1990-11-15 1991-11-08 Fremgangsmåde til fremstilling af tabletter indeholdende cephalosporansyrederivater ved direkte komprimering
CA002094122A CA2094122C (fr) 1990-11-15 1991-11-08 Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique
PCT/FR1991/000872 WO1992008463A1 (fr) 1990-11-15 1991-11-08 Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique
ES91920476T ES2060417T3 (es) 1990-11-15 1991-11-08 Procedimiento para la preparacion por compresion directa de comprimidos de derivados del acido cefalosporanico.
US08/064,049 US5514383A (en) 1990-11-15 1991-11-08 Process for the preparation of tablets of derivatives of cephalosporanic acid by direct compression
DE69104220T DE69104220T2 (de) 1990-11-15 1991-11-08 Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten.
KR1019930701448A KR100226386B1 (ko) 1990-11-15 1991-11-08 직접압축에 의하여 세팔로스포란산 유도체를 함유하는 정제를 제조하는 방법
AT91920476T ATE111734T1 (de) 1990-11-15 1991-11-08 Verfahren zur herstellung von direktkomprimierten, cephalosporansäure derivate enthaltendentabletten.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9014210A FR2669221B1 (fr) 1990-11-15 1990-11-15 Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique.

Publications (2)

Publication Number Publication Date
FR2669221A1 FR2669221A1 (fr) 1992-05-22
FR2669221B1 true FR2669221B1 (fr) 1993-01-15

Family

ID=9402216

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9014210A Expired - Fee Related FR2669221B1 (fr) 1990-11-15 1990-11-15 Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique.

Country Status (11)

Country Link
US (1) US5514383A (fr)
EP (1) EP0557389B1 (fr)
JP (1) JP3253074B2 (fr)
KR (1) KR100226386B1 (fr)
AT (1) ATE111734T1 (fr)
CA (1) CA2094122C (fr)
DE (1) DE69104220T2 (fr)
DK (1) DK0557389T3 (fr)
ES (1) ES2060417T3 (fr)
FR (1) FR2669221B1 (fr)
WO (1) WO1992008463A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
IE950946A1 (en) * 1994-12-14 1996-06-26 Enbalt Trading Ltd Pharmaceutical tablet formulations.
IL125214A0 (en) * 1996-02-29 1999-03-12 Fujisawa Pharmaceutical Co Beta-lactam antibiotic-containing tablet and method for producing the same
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
US5735891A (en) * 1996-12-02 1998-04-07 Sulzer Intermedics Inc. Self-clamping anchoring sleeve
AU1232500A (en) * 1998-10-30 2000-05-22 Fuisz International Ltd. Improved amoxycillin and clavulanate composition
KR20030078105A (ko) * 2002-03-28 2003-10-08 (주)다산메디켐 제약 및 식품산업의 정제 제조시 반드시 거쳐야 하는공정인 타정(정제의 제조) 공정에서 타정을 위한 분체혼합물의 유동성을 개선하고 타정 공정시 발생되는타정장애 중 특히 타정물이 타정기 또는 타정펀치에 붙든현상인 점착성 발생을 없앤 제약산업에서 사용될 수 있는고형제제를 위한 직타용 부형제의 새로운 조성물에관한것이다.
US7803402B2 (en) * 2002-07-06 2010-09-28 Sanjeev Khandelwal Pharmaceutical preparations
BRPI0418769A (pt) * 2004-05-10 2007-10-09 Lupin Ltd composição farmacêutica compreendendo cefixima, processo para a preparação de uma forma de dosagem oral sólida compreendendo de partìculas de cefixima, método para conseguir bio-equivalência entre a forma de dosagem oral e uma suspensão e comprimido mastigável compreendendo cefixima
CN110041346B (zh) * 2019-04-17 2022-06-07 广东立国制药有限公司 一种低成本的头孢克肟的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR208171A1 (es) * 1972-09-29 1976-12-09 Ciba Geigy Ag Procedimiento para la obtencion de nuevos derivados del acido cef-3-em-4-carboxilico
US4708956A (en) * 1985-12-12 1987-11-24 Kyowa Hakko Kogyo Co., Ltd. 3-position halogenated cephalosporin analogs and pharmaceutical compositions
JPH01149728A (ja) * 1987-12-04 1989-06-12 Fujisawa Pharmaceut Co Ltd 抗潰瘍剤
JPH01242589A (ja) * 1988-03-22 1989-09-27 Fujisawa Pharmaceut Co Ltd セフエム化合物
IL94946A0 (en) * 1989-07-13 1991-06-10 Eisai Co Ltd 3-substituted vinyl cephalosporin derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0557389A1 (fr) 1993-09-01
KR100226386B1 (ko) 1999-10-15
US5514383A (en) 1996-05-07
JPH06502420A (ja) 1994-03-17
CA2094122C (fr) 2004-07-20
DE69104220T2 (de) 1995-01-26
ES2060417T3 (es) 1994-11-16
WO1992008463A1 (fr) 1992-05-29
KR930702004A (ko) 1993-09-08
ATE111734T1 (de) 1994-10-15
CA2094122A1 (fr) 1992-05-16
JP3253074B2 (ja) 2002-02-04
DK0557389T3 (da) 1994-10-17
EP0557389B1 (fr) 1994-09-21
DE69104220D1 (de) 1994-10-27
FR2669221A1 (fr) 1992-05-22

Similar Documents

Publication Publication Date Title
GB2210879B (en) 4h-1-benzopyran-4-one derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
TNSN92022A1 (fr) Procede de preparation de nouveaux derives de l'indole
HUT68357A (en) Heterocyclic-cyclic-amine derivatives, pharmaceutical compositions containing them and process for their production
FI20011852A7 (fi) Menetelmä fluoksetiinia tai sen happoadditiosuolaa sisältävän dispergoituvan tabletin valmistamiseksi
YU56995A (sh) Soli derivata indola
RU93049997A (ru) Производные метилен-бис-фосфоновой кислоты, способ их получения, фармацевтическая композиция
DE3369508D1 (en) Triphenylimidazolyloxyalcanoic acids and their derivatives, process for their preparation and pharmaceutical compositions containing them
UA19782A (uk) Спосіб одержаhhя біциклічhих складhих ефірів або їх фармацевтичhо прийhятhих солей
FR2669221B1 (fr) Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique.
RU92016595A (ru) Замещенные тиазолильные и замещенные пиридинильные производные, фармацевтическая композиция и способ их получения
GR3019796T3 (en) Quinolone carboxylic acid derivatives, process for their preparation and their use
HU9201789D0 (en) Process for the production of substituted diamino-phtalimides and their analogues
CZ282732B6 (cs) Substituované 1,2,3,4-tetrahydrocyklopent/b/indoly, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoly a příbuzné sloučeniny, meziprodukty a způsob jejich přípravy a jejich použití jako léčiv
AU1122288A (en) Intermediates for the production of halogenated protease inhibitors
ES8605532A1 (es) Un procedimiento para preparar derivados de aminoglicosido
NO975921L (no) Fremstilling av bicykloheksanderivater
DK0625153T3 (da) Nyt isoindolinonderivat, dets fremstilling og farmaceutiske præparater med et indhold deraf
BR9611572A (pt) Produção de um sal de ácido clavulânico
ES8302669A1 (es) "procedimiento de preparacion de nuevos derivados, solubles, n2 sustituidos de la diamino-2,4-bencil-5-pirimidina".
TW244350B (fr)
ES8504160A1 (es) Procedimiento para la preparacion de derivados de propan-2-ol
AU1466592A (en) Gem-diphosphonic acid nitrosocarbamoyl derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
ES8300747A1 (es) Procedimiento para la preparacion de derivados de acido in- dolacetico
CA2022323A1 (fr) Excretion d'ions potassium par des derives de l'acide prostanoique
JPS6447729A (en) Leukotriene antagonist and manufacture

Legal Events

Date Code Title Description
ST Notification of lapse